Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Six African American women experienced hair loss after switching to a new HIV medication.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Leucaena seeds are nutritious but need treatment to reduce toxicity.

Hair loss doesn't affect COVID-19 severity.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Tisseel shows promise for bone graft stabilization but needs more clinical trials to confirm its effectiveness.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Low testosterone may increase COVID-19 severity in men.

Combination therapy with QR 678 Neo and 5% Minoxidil is most effective for male hair loss.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Iron nanoparticles made from pumpkin extract effectively treated burns and promoted healing in mice.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Pluripotent stem cells show promise for treating skin color loss disorders like vitiligo.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Raltegravir may cause hair loss in some patients.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Balancing testosterone may reduce COVID-19 severity.

The hydrogel speeds up diabetic wound healing and reduces scarring.

Early diagnosis and comprehensive management improve life quality for Netherton syndrome patients.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

Doctors should consider Netherton syndrome in patients with chronic skin and hair issues to avoid misdiagnosis.

ADAM17 could be a potential target for treating PCOS.

Elastin-like recombinamers show promise for better wound healing and skin regeneration.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.